Endo International | ENDP - Marktkapitalisierung



Marktkapitalisierung Veränderung Datum
AbbVie USD 403.83B 5.2B 2025-12
Amarin USD 290M 51M 2025-12
ANI Pharmaceuticals USD 1.77B 269M 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Heron Therapeutics USD 238M 7M 2025-12
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Merck USD 261.26B 51.62B 2025-12
Novartis USD 292.21B 26.55B 2025-12
Pacira USD 1.06B 94M 2025-12
Perrigo USD 1.92B 1.04B 2025-12
Pfizer USD 141.57B 6.48B 2025-12
Phibro Animal Health USD 1.51B 126M 2025-12
Supernus Pharmaceuticals USD 2.85B 151M 2025-12
Takeda JPY 7.64T 774.9B 2025-12
Teva Pharmaceutical Industries USD 36.42B 14.06B 2025-12
Xeris Pharmaceuticals USD 1.3B 12M 2025-12
Zoetis USD 55.45B 9.4B 2025-12